1369800-37-2

Basic information

• Product Name: 3-[(4-bromobenzyl)sulfanyl]dihydrofuran-2(3H)-one
• Synonyms: 3-[(4-bromobenzyl)sulfanyl]dihydrofuran-2(3H)-one
• CAS NO: 1369800-37-2
• Molecular Weight: 287.177
• Mol File: 1369800-37-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-[(4-bromobenzyl)sulfanyl]dihydrofuran-2(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(4-bromobenzyl)sulfanyl]dihydrofuran-2(3H)-one(1369800-37-2)
• EPA Substance Registry System: 3-[(4-bromobenzyl)sulfanyl]dihydrofuran-2(3H)-one(1369800-37-2)

Safety Data

• Hazardous Substances Data: 1369800-37-2(Hazardous Substances Data)

Upstream product

• 14032-62-3 2-mercapto-γ-butyrolactone 
• 589-15-1 1-bromomethyl-4-bromobenzene 

Downstream Products

• 1369801-93-3 2-{[(4'-chlorobiphenyl-4-yl)methyl]sulfanyl}-4-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)butanoic acid 
• 1369801-99-9 prop-2-en-1-yl-2-{[(4'-chlorobiphenyl-4-yl)methyl]sulfanyl}-4-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)butanoate 
• 1369802-35-6 2-{[(4'-chlorobiphenyl-4-yl)methyl]sulfonyl}-4-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)butanoic acid 

Relevant articles and documents

MATRIX METALLOPROTEINASE INHIBITORS

This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis, pulmonary inflammation, acute respiratory distress syndrome, periodontitis, multiple sclerosis, gingivitis, gingivitis, atherosclerosis, dry eye, neointimal proliferation, which leads to restenosis and ischemic heart failure, stroke, renal diseases, tumor metastasis, and pounds.